Literature DB >> 3872599

Effects of deoxycoformycin in mice. III. A murine model reproducing multi-system pathology of human adenosine deaminase deficiency.

H Ratech, R Hirschhorn, G J Thorbecke.   

Abstract

Adult AKR/J mice were treated with 10 micrograms/g or 100 micrograms/g 2'-deoxycoformycin, an adenosine deaminase inhibitor with chemotherapeutic potential. The thymus and adrenal glands were decreased in weight more than any other organ. Histologic and cytofluorographic analyses indicated preferential depletion of peanut-agglutinin-positive, cortical thymocytes, as well as acute, dose-dependent damage to the adrenal cortex and medulla. The effect of 2'-deoxycoformycin on the thymus was proven to be independent of the adrenal glands by use of adrenalectomized mice. Dose-dependent liver necrosis, hemolysis, and leukemoid reactivity were observed. These findings illustrate a differential sensitivity of thymocyte subpopulations and suggest, in addition, preferential sensitivity of certain nonlymphoid tissues to 2'-deoxycoformycin administered in vivo.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872599      PMCID: PMC1888086     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  14 in total

1.  Separation of mouse thymocytes into two subpopulations by the use of peanut agglutinin.

Authors:  Y Reisner; M Linker-Israeli; N Sharon
Journal:  Cell Immunol       Date:  1976-07       Impact factor: 4.868

2.  Effects of 2'-deoxycoformycin infusion on mouse adenosine deaminase.

Authors:  A Tedde; M E Balis; R Schonberg; P P Trotta
Journal:  Cancer Res       Date:  1979-08       Impact factor: 12.701

3.  Serum xanthine oxidase and liver disease.

Authors:  C Ramboer; F Piessens; J De Groote
Journal:  Digestion       Date:  1972       Impact factor: 3.216

4.  Hereditary hemolytic anemia with increased red cell adenosine deaminase (45- to 70-fold) and decreased adenosine triphosphate.

Authors:  W N Valentine; D E Paglia; A P Tartaglia; F Gilsanz
Journal:  Science       Date:  1977-02-25       Impact factor: 47.728

5.  In vivo toxicity to lymphoid tissue by 2'-deoxycoformycin.

Authors:  J F Smyth; R C Young; D M Young
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

6.  Immunosuppression by 2' deoxycoformycin: studies on the mode of administration.

Authors:  E M Sordillo; S Ikehara; R A Good; P P Trotta
Journal:  Cell Immunol       Date:  1981-09-15       Impact factor: 4.868

7.  Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.

Authors:  C M Smith; A Belch; J F Henderson
Journal:  Biochem Pharmacol       Date:  1980-04-15       Impact factor: 5.858

8.  Identification and quantitation of adenine deoxynucleotides in erythrocytes of a patient with adenosine deaminase deficiency and severe combined immunodeficiency.

Authors:  M S Coleman; J Donofrio; J J Hutton; L Hahn; A Daoud; B Lampkin; J Dyminski
Journal:  J Biol Chem       Date:  1978-03-10       Impact factor: 5.157

9.  ATP depletion as a consequence of adenosine deaminase inhibition in man.

Authors:  M F Siaw; B S Mitchell; C A Koller; M S Coleman; J J Hutton
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

10.  Animal model for immune dysfunction associated with adenosine deaminase deficiency.

Authors:  A Tedde; M E Balis; S Ikehara; R Pahwa; R A Good; P P Trotta
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

View more
  3 in total

1.  Metabolites from apoptotic thymocytes inhibit thymopoiesis in adenosine deaminase-deficient fetal thymic organ cultures.

Authors:  L F Thompson; C J Van de Wiele; A B Laurent; S W Hooker; J G Vaughn; H Jiang; K Khare; R E Kellems; M R Blackburn; M S Hershfield; R Resta
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

2.  Pathologic findings in adenosine deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterations.

Authors:  H Ratech; M A Greco; G Gallo; D L Rimoin; H Kamino; R Hirschhorn
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

3.  p53 expression is required for thymocyte apoptosis induced by adenosine deaminase deficiency.

Authors:  P Benveniste; A Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.